RELIQ HEALTH TECHS INC - RQHTF STOCK NEWS

Reliq Health Technologies Inc. (OTCQB:RQHTF) reported significant growth in its Q3 FY2022 financial results. Revenues surged over 490% to $6,263,304 compared to the same period last year. The company aims to generate the majority of its income from software and services sales, with gross margins rising from 47% to 70%. Despite challenges from COVID-19, software revenue increased 200% quarter-over-quarter. New agreements with Data Soft Logic and Cognizant expand Reliq’s market access, while the introduction of new billing codes for Remote Therapeutic Monitoring increases the eligible patient pool by 20 million.

Reliq Health Technologies Inc. (OTC:RQHTF) will host a webinar on May 31, 2022, at 6:00am PST / 9:00am EST to discuss its Q3 Fiscal Year 2022 financial results and provide a corporate update. The webinar aims to enhance shareholder engagement by reviewing the company's growth in Virtual Care technology. Those unable to attend can access a recording on the company website after the session. Reliq Health develops innovative solutions to improve patient care while reducing costs, emphasizing its iUGO Care platform.

Reliq Health Technologies Inc. (OTCPink:RQHTF) is launching its first clinical trials this month, targeting hypertension and oncology. The trials, utilizing the iUGO Care platform, are expected to enroll over 1,000 patients, generating an average revenue of US$40 per patient monthly with a 75% gross margin. Additionally, Reliq has signed four contracts in Texas and Florida, projected to onboard 2,000 patients by year-end, potentially adding CDN$150,000 monthly in gross revenue. Shares are currently trading at $0.58.

Reliq Health Technologies (OTC:RQHTF) announced that its iUGO Care platform will launch in two clinical trials this month, enrolling over 1,000 patients focused on hypertension and oncology. The company signed four new contracts in Texas and Florida, expected to onboard an additional 2,000 patients by year-end. Revenue generation is projected at $40 per patient per month for the trials and over $60 for new contracts, both at a gross margin of 75%. This expansion underlines Reliq's growth in the healthcare technology market.

Reliq Health Technologies Inc. (OTC:RQHTF) announced new contracts with six physician practices and two home health agencies, aiming to onboard over 5,000 patients across California, Michigan, Nevada, and Texas in 2022. These contracts are expected to generate more than $60 in revenue per patient monthly at a 75% gross margin. The company also integrated the MiUGO patient portal into its Remote Therapeutic Monitoring (RTM) module, enhancing patient symptom tracking for musculoskeletal and respiratory conditions, which may lead to improved health outcomes and reduced hospital admissions.

Reliq Health Technologies has secured contracts to onboard over 8,000 new patients, enhancing its telemedicine capabilities. These contracts involve three physician practices across Texas, California, and a health network in Nevada. The company's iUGO Care platform is expected to generate an average revenue exceeding $60 per patient per month, translating to an anticipated increase of over CDN$600,000 monthly. Reliq’s solutions aim to reduce healthcare costs significantly, improving patient care and financial performance.

Reliq Health Technologies Inc. (OTC:RQHTF) announced the signing of four new contracts with three physician practices in Texas and California, and a health network in Nevada. These agreements are expected to add over 8,000 new patients to Reliq’s iUGO Care platform. The new clients will generate an average revenue of over $60 per patient per month at a 75% gross margin. The increasing market demand for remote patient monitoring and chronic care management is allowing physicians to collect over $400 per patient monthly, contributing to improved health outcomes and reduced healthcare costs.

Reliq Health Technologies Inc. (OTC:RQHTF) announced new contracts with two physician practices, a hospital, and a Skilled Nursing Facility in California, Texas, and Nevada. These clients will employ the iUGO Care platform's modules for effective Transitional Care Management and Remote Patient Monitoring. The company expects over 1,000 patients from these facilities to generate $50 per patient per month at a 75% gross margin. Additionally, over 1,500 patients from physician practices are projected to onboard in June, expected to generate $65 per patient per month at the same margin, enhancing overall healthcare outcomes.

Reliq Health Technologies Inc. (OTC: RQHTF) condemned a recent report from a short seller as defamatory and misleading, aimed at manipulating its stock price. The company noted over 5 million shares are currently shorted, a significant increase preceding the report. Despite the tumultuous healthcare landscape due to COVID-19, Reliq reported a remarkable 494% revenue growth over the past four quarters and expects to onboard over 200,000 patients by mid-2023, driven by expanding Medicare and Medicaid reimbursements. The company plans to submit evidence of false claims to the DOJ amid an ongoing investigation into short selling practices.